Decreased N-myc expression in human medulloblastoma cell lines during differentiation

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 301-306

  Moriuchi, Shusuke ^a   Shimizu, Keiji ^b   Miyao, Yasuyoshi ^b   Kishima, Haruhiko ^b   Okawa, Motohisa ^b   Hayakawa, Toru ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Brain tumor; Cell differentiation; Cellular (N myc); Medulloblastoma; Oncogene; Prognostic factor

Indexed keywords

BUCLADESINE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; ONCOGENE C MYB; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR CELLS, CULTURED;

EID: 0031056903     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dehner LP: Peripheral and central primitive neuroectodermal tumors. Arch Pathol Lab Med 110: 997-1005, 1986.
2. Rorke LB: The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42: 1-15, 1983.
3. Rorke LB, Gilles FH, Davis RL, Becker LE: Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56: 1869-1886, 1985.
4. Rorke LB: Origin and histogenesis of medulloblastoma. In: Zeltzer PM, Pochedly C, (ed). Medulloblastomas in Children, New York, Praeger, 1986, pp14-21.
5. Brodeur GM, Seeger RC: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Wash. DC) 224: 1121-1124, 1984.
6. Brodeur GM, Seeger RC, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D: Clinical implications of oncogene activation in humun neuroblastomas. Cancer (Phila.) 58: 541-545, 1986.
7. Kohl NE, Gee CE, Alt FW: Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science (Wash. DC) 226: 1335-1337, 1984.
8. Seeger RC, Brodeur GM, Asthe H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Eng J Med 313: 1111-1116, 1985.
9. Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K: Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer (Phila.) 60: 820-826, 1987.
10. Nisen PD, Zimmerman KA, Cotter SV, Gilbert F, Alt FW: Enhanced expression of the N-wyc gene in Wilms' tumors. Cancer Res 46: 6217-6222, 1986.
11. Matsumoto M, Akiyama T, Miyatake S, Oda Y, Kikuchi H, Hanaoka M, Namba Y: Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line. SK-N-DZ. Acta Neuropathol 79: 217-221, 1989.
12. Tamura K, Shimizu K, Yamada M, Okamoto Y, Matsui Y, Park K, Mabuchi E, Moriuchi S, Mogami H: Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation. Cancer Res 49: 5380-5384, 1989.
13. Sugimoto T, Tatsumi E, Kemshed JT, Helson L, Green AA, Minowada J: Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lympboma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst 73: 51-57, 1984.
14. Ikegaki N, Bukovsky J, Kennett RH: Identification and characterization of N-myc gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc Natl Acad Sci 83: 5929-5933, 1986.
15. Bradford M: A rapid and sensitive method for the tion of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
16. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 762: 156-159, 1987.
17. Garson JA, Pemberton LF, Sheppard PW, Varndell IM, Coakham HB, Kemshead JT: N-myc gene expression and oncoprotein characterization in medulloblastoma. Br J Cancer 59: 889-894, 1989.
18. Makela TP, Saksela K, Alitalo K: Two N-myc polypeptides with distinct amino termini encoded by the second and the third exons of the gene. Molec Cell Biol 9: 1545-1552, 1989.
19. Finklestein R, Weiberg R: Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells. Oncogene Res 3: 287-292, 1988.
20. Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56: 1106-1111, 1985.
21. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50: 2347-2350, 1990.